Evaluating the Clinical Efficacy and Safety of Subcutaneous Rituximab in Non-Hodgkin Lymphoma: A Systematic Review. (2024). The Medical Journal of General Medicine, 1(1), 1-16. https://medicaljournalinternational.org/tmjgm/article/view/1 (Original work published 2024)